MedPath
HSA Approval

HOSOLVON TABLET 8 mg

SIN05034P

HOSOLVON TABLET 8 mg

HOSOLVON TABLET 8 mg

August 30, 1990

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R05CB02

bromhexine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

HOVID Bhd.

Active Ingredients

BROMHEXINE HYDROCHLORIDE

8.00mg

Bromhexine

Documents

Package Inserts

Hosolvon PI.pdf

Approved: April 28, 2017

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HOSOLVON TABLET 8 mg - HSA Approval | MedPath